The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids

Environmental Health Perspectives

Volumn 106, Issue 12, 1998, Pages 807-812

  Verma, Surendra P ^a   Goldin, Barry R ^a   Lin, Peck S ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Curcumin; Estrogenic chemicals; Human breast cancer cells; Isoflavonoids; Pesticides

Indexed keywords

CHLORPHENOTANE; CURCUMIN; ENVIRONMENTAL CHEMICAL; ESTROGEN; ESTROGEN RECEPTOR; GENISTEIN; ISOFLAVONOID; PESTICIDE; PHENOL DERIVATIVE; PLANT EXTRACT;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; ESTROGEN ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0032466079     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.106-1533252     Document Type: Article

References (36)

1. Perera FP. Environment and cancer: who are susceptible? Science 278:1068-1073 (1997).
2. Estrogens in the environment III: global health implications. Environ Health Perspect 103(suppl 7) (1995).
3. Falck F, Ricci AJ, Wolff MS, Godbold J, Deckers P. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47:143-146 (1992).
4. Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85:648-652 (1993).
5. Dewailly E, Dodin S, Verreault R, Ayotte P, Sauve L, Morin J, Brisson J. High organochlorine body burden in women with estrogen receptor positive breast cancer. J Natl Cancer Inst 86:232-234 (1994).
6. Katzenellenbogen BS, Montano MM, Le Goff P, Schodin DJ, Kraus WL, Bhardwaj B, Fujimoto NJ. Antiestrogens: mechanisms and actions in target cells. Steroid Biochem Mol Biol 53:337-393 (1995).
7. Gottardis MM, Jordan VC. Development of tamoxifen-stimulated growth of MCF-7 tumor in athymic mouse after long-term antiestrogen administration. Cancer Res 48:5183-5187 (1983).
8. de Jong PC, van de Ven J, Nortier HWR. Maitimu-Smeele I, Donker TH, Thijssen JHH, Slee PHTJ, Blankenstein RA. Inhibition of breast cancer tissus aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole. Cancer Res 57:2109-2111 (1997).
9. Huang M-T, Lou Y-R, Ma W, Newmark HL, Reuhl KR, Conney AH. Inhibitory effects of dietary curcumin on forestomach, duodenal and colon carcinogenesis. Cancer Res 54:5841-5847 (1994).
10. Huang M-T, Ma W, Lu Y-P, Chang RL, Fisher C, Manchand PS, Newmark HL, Conney AH. Effect of curcumin, dimethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Carcinogenesis 16:2493-2497 (1995).
11. Rao CV, Simi B, Reddy BS. Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis 14:2219-2225 (1993).
12. Rao CV, Rivenson A, Simi B, Reddy BS. Chemoprevention of colon carcinogenasis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55:259-266 (1995).
13. Samaha HS, Kelloff GR, Steele V, Rao CV, Reddy BS. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res 57:1301-1305 (1937).
14. Stoner GD, Mukhtar H. Polyphenols as cancer chemoproventive agents. J Cell Biochem Suppl 22:169-180 (1995).
15. Singletary K, MacDonald C, Wallig M, Fisher C. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin. Cancer Lett 103:137-141 (1996).
16. Sacks PG, Khaffif A, Al-Rawi M, Dennergberg AJ, Schantz SP. Antiproliferative effects of curcumin and (-)-epigallocatechin 3-gallate (EGCG) on normal and premalignant human oral epithelial cells [abstract]. Proc Am Assoc Cancer Res 36:261 (1997).
17. Korutla L, Cheung JY, Mendelsohn J, Kumar R. Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis 16:1741-1745 (1935).
18. Chan MM. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 26:1551-1556 (1995).
19. Liu JY, Lin SJ, Lin JK. Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis 14:857-861 (1993).
20. Singh S, Aggarwal BB. Activation of transcription factor NF-κB is suppressed by curcumin (diferulolylmethane). J Biol Chem 270:24995-25000 (1995).
21. Kakar SS, Roy D. Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogene messenger RNAs in mouse skin. Cancer Lett 87:85-89 (1994).
22. Huang TS, Lee SC, Lin JK. Suppression of c-jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proc Natl Acad Sci USA. 88:5292-5296 (1991).
23. Mazumder A, Wang S, Neamari N, Nicklaus M, Sunder S, Chen J, Milane GW, Rice WG, Burke TR Jr, Pommier Y. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease. J Med Chem 39:2472-2431 (1996).
24. Ruby A, Kuttan G, Babu K, Rajasekharan K, Kuttan R. Anti-tumor and antioxidant activity of natural curcuminoids. Cancer Lett 94:79-83 (1995).
25. Adlercreutz H. Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 103(suppl 7):103-112 (1996).
26. Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wahala K, Montesano R, Schweigerer L. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 57:2916-2921 (1997).
27. Adlercreutz H, Goldin BR, Gorbach SL, Hockerstedt KAV, Watanabe S, Hamalainen EK, Markkanen MH, Makela TH, Wahala KT, Hase TA, Fotsis T. Soybean phytoestrogen intake and cancer risk. J Nutr 125:7575-7705 (1995).
28. Verma SP, Goldin BR. The effect of soy-derived isoflavonoids toward the induced growth of MCF-7 cells by estrogenic environmental chemicals. Nutr Cancer 30:232-239 (1998).
29. So FV, Guthrie N, Chambers AF, Carroll KK. Inhibition of proliferation of estrogen-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett 112:127-133 (1997).
30. Balabhadrapathruni S, Thomas T, Thomas TJ. Estrogenic and antiestrogenic actions of genistein in human breast cancer cell growth mediated through the polyamina pathway [abstract]. Proc Am Assoc Cancer Res 38:207 (1997).
31. Verma SP, Salamone E, Goldin BR. Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides. Biochem Biophys Res Commun 233:692-696 (1997).
32. Soto AM, Justicia H, Wray JW, Sonnenschein C. p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene. Environ Health Perspect 92:167-173 (1991).
33. Smith WL. Prostanoid biosynthesis and mechanisms of action. Am J Physiol 263:F181-F191 (1992).
34. Timer J, Chen YO, Liu B, Bazar R, Taylor JD, Honn KV. The lipoxygenase metabolite 12(S)-HETE promotes alphaII beta3 integrin-mediated tumor cell spreading on fibronectin. Int J Cancer 52:594-603 (1992).
35. Dennis AE, Rhee SG, Billah MM, Hannun YA. A role of phospholipases in generating lipid second messengers in signal transduction. FASEB J 5:2068-2077 (1991).
36. Arteaga CL, Johnson MD, Todderud G, Cofey RJ, Carpenter G, Page DL Elevated content of the tyrosine kinase substrate phospholipase Cgama1 in primary human breast carcinomas. Proc Natl Acad Sci USA 88:10435-10439 (1991).